Evolution of AR and Non-AR Alterations in ctDNA of Patients with Metastatic Prostate Cancer Treated in the Phase III Alliance A031201 Trial
      QxMD      Google Scholar   
Citation:
Clin Cancer Res vol 32 (12) 2413-27
Year:
2026
Type:
Manuscript
Funding:
NCTN
Endpoint:
Secondary-not-in-original
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
ppub
Note:
Methodological:
No
Biospecimen:
Yes
SDC:
No
Book Volume:
15
Parents:
None
Children:
None
Program:
OGC
Primary Committee:
GU
Sec. Committees:
   
Pharmas:
Astellas  
Grants:
U10CA180821, U10CA180882, U24CA196171, UG1CA233253, UG1CA233290, UG1CA233180  
Corr. Author:
 
Authors:
                                     
Networks:
LAPS-MA036, LAPS-NC010, LAPS-NY016, MN022   
Study
Alliance-A031201
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
3
Keywords: